INVO Bioscience (INVO)
NASDAQ:INVO
US Market

INVO Bioscience (INVO) Financial Statements

121 Followers

INVO Bioscience Financial Overview

INVO Bioscience's market cap is currently ―. The company's EPS TTM is $-4.982; its P/E ratio is -0.15; INVO Bioscience is scheduled to report earnings on August 12, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 1.58M$ 1.38M$ 974.89K$ 254.36K$ 297.38K
Gross Profit$ 726.05K$ 495.00K$ 393.93K$ 315.90K$ 275.47K
EBIT$ -1.41M$ -1.79M$ -894.47K$ -2.06M$ 2.97M
EBITDA$ -1.19M$ -1.65M$ -873.97K$ -1.98M$ 3.23M
Net Income Common Stockholders$ -1.60M$ -1.99M$ -1.25M$ -2.24M$ 2.76M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 475.13K$ 232.42K$ 1.06M$ 112.48K$ 2.19M
Total Assets$ 18.32M$ 20.89M$ 19.48M$ 6.64M$ 6.15M
Total Debt$ 4.70M$ 7.17M$ 7.10M$ 4.10M$ 1.84M
Net Debt$ 4.23M$ 6.94M$ 6.05M$ 3.99M$ -343.46K
Total Liabilities$ 18.31M$ 18.49M$ 19.10M$ 8.34M$ 6.06M
Stockholders Equity$ 10.15K$ 892.83K$ 372.80K$ -1.71M$ 88.47K
Cash Flow-
Free Cash Flow$ -284.67K$ -789.88K$ -1.36M$ -1.91M$ -1.15M
Operating Cash Flow$ -260.56K$ -714.88K$ -1.25M$ -1.64M$ -1.15M
Investing Cash Flow$ -24.11K$ 33.29K$ -2.26M$ -261.50K$ -8.45K
Financing Cash Flow$ 527.37K$ -141.53K$ 4.45M$ -169.86K$ 3.26M
Currency in USD

INVO Bioscience Earnings and Revenue History

INVO Bioscience Debt to Assets

INVO Bioscience Cash Flow

INVO Bioscience Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis